Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000389371 | SCV000474426 | uncertain significance | CHARGE syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000295140 | SCV000474427 | uncertain significance | Hypogonadism with anosmia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317861 | SCV000850875 | likely benign | Inborn genetic diseases | 2017-04-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000389371 | SCV001004234 | benign | CHARGE syndrome | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001567504 | SCV001791203 | likely benign | not provided | 2022-04-25 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Ce |
RCV001567504 | SCV004155852 | likely benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | CHD7: BP4, BP7 |